Aim immunotech provides update regarding annual meeting

Ocala, fla.--(business wire)--aim immunotech inc. (nyse american: aim) (“aim” or the “company”) today announced that the company will convene its upcoming 2023 annual meeting of stockholders (the “2023 annual meeting”) as planned on december 1, 2023, and will then adjourn proceedings, without conducting any other business, until december 29, 2023. the purpose of the adjournment is to provide the delaware court of chancery (the “court”) with sufficient time to issue a ruling with respect to the.
AIM Ratings Summary
AIM Quant Ranking